Integral Molecular is a research-driven biotechnology company creating innovative technologies and therapeutic antibodies for under-exploited membrane protein targets, including GPCRs, ion channels, transporters, and viral envelopes.

15+ years experience optimizing membrane proteins

Work with Top 10 pharmaceutical companies

300+ customers and partners

Upcoming Events

J.P. Morgan Annual Healthcare Conference
January 11-14 | Virtual

SOT Annual Meeting
March 14-18 | Virtual

PEGS Boston
May 11-14